Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

August 4-5, 2017

Philadelphia, PA

Dear Colleagues,

Join us August 4-5, 2017 in Philadelphia, PA for the US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes! This meeting promises to be a first-class educational event that focuses on the latest advances in myeloproliferative neoplasm (MPN) and myelodysplastic syndromes (MDS).

This conference will provide a platform to resolve many of the clinical challenges, diagnosis, and treatment of MPN and MDS through presentations and interactive discussions of the latest clinical and research findings. Topics that will be discussed by recognized experts during the conference include the underlying biology of MPN and MDS, how these events impact clinical practice, and updates in therapeutic interventions, Gained knowledge from this meeting will provide new methods and strategies for diagnosis, risk stratification, and the identification of optimal therapeutics for the enhancement of clinical outcomes and quality of life in patients with MPN and MDS.

As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals who care for patients with MPN and MDS are provided an expert review of the most pertinent clinical data pertaining to prognosis, diagnosis, therapy and disease management and guidance for their optimal integration into everyday clinical practice. The US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes will bring to the United States the same outstanding, clinically-relevant knowledge pertaining to MPN and MDS that has been provided to the European medical community through its sister conference.

With few other meetings of this type currently in the United States, this highly-relevant clinical conference will provide the basis to advance understanding, drive optimal therapeutic strategies, and improve patient outcomes for MPN and MDS. With its diverse mix of didactic presentations and interactive discussion, you will have the opportunity to update your knowledge in the field, confirm your current practices, and receive valuable take-home information including new screening and staging modalities, management approaches and emerging treatment options.

We look forward to seeing you in August, for what is sure to be an educational and informative scientific meeting.


Srdan Verstovsek, MD, PhD Rami Komrokji, MD

Conference Chair:
Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center
The University of Texas
Houston, Texas

Conference Chair:
Rami Komrokji, MD
H. Lee Moffitt Cancer Center
& Research Institute
Tampa, Florida

Important Dates

Early Registration Deadline June 15, 2017
Discounted Registration Deadline July 20, 2017
Presentation Dates August 4-5, 2017


11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334

For registration inquiries:
Tel.: +1 (800) 233-0957
Direct:  +1 (678) 242-0906 
Fax: +1 (678) 242-0920